AhR activation enhances nuclear translocation and expression of nuclear factor erythroid 2-related factor 2 (NRF2), reduces reactive oxygen species (ROS) accumulation, and inhibits ferroptosis, providing a potential therapeutic target for the treatment of acute kidney injury (AKI) [36]. Here, NFE2L2 is linked to acute kidney injury.